Blood group ABO polymorphism inhibits SARS‐CoV‐2 infection and affects COVID‐19 progression.
Autor: | Yamamoto, Fumiichiro1 (AUTHOR) fyamamoto@carrerasresearch.org, Yamamoto, Miyako1 (AUTHOR), Muñiz‐Diaz, Eduardo2 (AUTHOR) |
---|---|
Zdroj: | Vox Sanguinis. Jan2021, Vol. 116 Issue 1, p15-17. 3p. 1 Diagram. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |